MFG
CMPX icon

Merit Financial Group’s Compass Therapeutics CMPX Stock Holding History

Merit Financial Group’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.8K Buy
+23,674
New +$69.9K ﹤0.01% 2276

Other funds holding CMPX

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return
WCP
Wealthcare Capital Partners West Chester, Pennsylvania $242M AUM 18.96% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Merit Financial Group's CMPX Position: Q2 2026 in Review

Merit Financial Group opened a new position in Compass Therapeutics (CMPX) in Q2 2026: 23,674 shares worth $51.8K. The stake represents ﹤0.01% of the portfolio and ranks #2276 among its holdings.

9 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Merit Financial Group held 23,674 shares of Compass Therapeutics worth $51.8K as of Q2 2026.
  • Compass Therapeutics was a new Merit Financial Group position in Q2 2026.
  • Compass Therapeutics made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #2276 holding.
  • 9 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.